CGH
AMGN icon

Crossmark Global Holdings’s Amgen AMGN Stock Holding History

Crossmark Global Holdings’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6M Buy
40,262
+1,002
+3% +$343K 0.19% 121
2026
Q1 		$13.8M Sell
39,260
-8,456
-18% -$3.01M 0.2% 117
2025
Q4 		$15.6M Buy
47,716
+4,922
+12% +$1.56M 0.22% 99
2025
Q3 		$12.1M Buy
42,794
+1,178
+3% +$342K 0.18% 136
2025
Q2 		$11.6M Sell
41,616
-39,273
-49% -$11.1M 0.19% 133
2025
Q1 		$25.2M Buy
80,889
+4,282
+6% +$1.26M 0.44% 43
2024
Q4 		$20M Buy
76,607
+1,966
+3% +$583K 0.36% 60
2024
Q3 		$24.1M Sell
74,641
-517
-0.7% -$169K 0.43% 46
2024
Q2 		$23.5M Sell
75,158
-18,377
-20% -$5.4M 0.45% 40
2024
Q1 		$26.6M Sell
93,535
-19,880
-18% -$5.82M 0.51% 36
2023
Q4 		$32.7M Buy
113,415
+487
+0.4% +$133K 0.68% 24
2023
Q3 		$30.6M Buy
112,928
+46,426
+70% +$11.6M 0.69% 20
2023
Q2 		$15.7M Sell
66,502
-2,807
-4% -$651K 0.34% 64
2023
Q1 		$16.8M Buy
69,309
+1,621
+2% +$398K 0.39% 53
2022
Q4 		$17.8M Buy
67,688
+3,318
+5% +$889K 0.44% 44
2022
Q3 		$14.5M Buy
64,370
+8,621
+15% +$2.09M 0.4% 52
2022
Q2 		$13.6M Sell
55,749
-43,279
-44% -$10.6M 0.35% 62
2022
Q1 		$23.9M Sell
99,028
-649
-0.7% -$149K 0.53% 30
2021
Q4 		$22.4M Sell
99,677
-3,013
-3% -$636K 0.49% 33
2021
Q3 		$21.8M Buy
102,690
+1,026
+1% +$236K 0.51% 32
2021
Q2 		$24.8M Buy
101,664
+205
+0.2% +$50.4K 0.58% 27
2021
Q1 		$25.2M Sell
101,459
-3,360
-3% -$802K 0.63% 24
2020
Q4 		$24.1M Buy
104,819
+48,907
+87% +$11.3M 0.61% 26
2020
Q3 		$14.2M Buy
55,912
+303
+0.5% +$75.1K 0.4% 44
2020
Q2 		$13.1M Buy
55,609
+3,130
+6% +$714K 0.38% 53
2020
Q1 		$10.6M Buy
52,479
+1,043
+2% +$228K 0.38% 57
2019
Q4 		$12.4M Sell
51,436
-3,888
-7% -$857K 0.34% 72
2019
Q3 		$10.7M Sell
55,324
-6,353
-10% -$1.22M 0.31% 79
2019
Q2 		$11.4M Sell
61,677
-1,780
-3% -$319K 0.32% 73
2019
Q1 		$12.1M Sell
63,457
-1,654
-3% -$316K 0.34% 60
2018
Q4 		$12.7M Sell
65,111
-4,815
-7% -$939K 0.39% 49
2018
Q3 		$14.5M Sell
69,926
-5,346
-7% -$1.05M 0.37% 51
2018
Q2 		$13.9M Sell
75,272
-48,315
-39% -$8.55M 0.37% 49
2018
Q1 		$21.1M Sell
123,587
-9,084
-7% -$1.67M 0.54% 27
2017
Q4 		$23.1M Buy
132,671
+5,331
+4% +$943K 0.55% 26
2017
Q3 		$23.7M Buy
+127,340
New +$22.6M 0.61% 25
2016
Q3 		$23.7M Buy
+127,340
New +$21.5M 0.61% 25

Other funds holding AMGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Crossmark Global Holdings's AMGN Position: Q2 2026 in Review

Crossmark Global Holdings increased its Amgen (AMGN) stake by 2.6% in Q2 2026, buying an estimated $343K and bringing the position to 40,262 shares worth $14.6M. The position accounts for 0.19% of the portfolio, ranked #121.

Crossmark Global Holdings first reported a position in AMGN in Q3 2016 and has held it in 37 quarters since. The position peaked at $32.7M in Q4 2023. 749 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Crossmark Global Holdings held 40,262 shares of Amgen worth $14.6M as of Q2 2026.
  • Crossmark Global Holdings bought 1,002 Amgen shares in Q2 2026, an estimated $343K.
  • Amgen made up 0.19% of Crossmark Global Holdings's portfolio in Q2 2026, its #121 holding.
  • Crossmark Global Holdings first reported a position in Amgen in Q3 2016 and has held it in 37 quarters since.
  • Crossmark Global Holdings's Amgen position peaked at $32.7M in Q4 2023.
  • 749 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.